Skip to content

Hyperbaric Prilocaine 2% for spinal anesthesia 60 or 80 mg: a dosing study in day care patients.

Hyperbaric Prilocaine 2% for spinal anesthesia 60 or 80 mg: a dosing study in day care patients. - Hyperbaric Prilocaine 2% for spinal anesthesia.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47932
Enrollment
100
Registered
2016-02-10
Start date
2016-05-17
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lokaal anesthesie tbv operatieve ingrepen in dagbehandeling back injection spinal anesthesia

Interventions

Use of 60 mg or 80 mg prilocaine 2% hyperbaric for lower limb surgery

Sponsors

anesthesiologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients requiring spinal anesthesia for lower limb surgery in day case surgery.

Exclusion criteria

Exclusion criteria: age younger than 18 yrs pregnancy allergy for prilocaine or other amide type local anesthetics hereditary or acquired methaemoglobinaemia severe heart conduction abnormalities * severe anaemia * unstable cardiac failure * hypovolemic, cardiogenic or other forms of circulatory shock *

Design outcomes

Primary

MeasureTime frame
Maximum block height (sensibility and motor) Time of regression to T10, L1 and S2 (sensibility) Time of regression of motor block Time to spontaneous urination or catherization

Secondary

MeasureTime frame
the amount of fluid infused during and after surgery and the amount of fluids taken postoperatively bladder volume pre and postoperatively and at discharge if the patient did not urinate yet time of first urine production. If the patient does not urinate during admission, he/she will be asked to record the time at home bladder catheterization if necessary and volume additional analgesics per and postoperatively use of vasopressors patient satisfaction with the procedure time of discharge, night admission if necessary and reason for night admission ****

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)